Psychedelic Science Research Papers | Page 4 | OpenScience.ink

1 week ago • Brain research

Increased brain signal variety, network disruption, and improved well-being during DMT use measured by EEGHigher signal diversity, network dysregulation, and increased well-being under DMT administration: An EEG study.

Article

1 week ago • Journal of psychoactive drugs

Users’ Reported Experiences with 5-MeO-DMT on Reddit: A Thematic OverviewExploratory Insights into 5-MeO-DMT Experiences on Reddit: A Thematic Analysis.

Article

1 week ago • Journal of psychopharmacology (Oxford, England)

Ketamine's effects on cell energy production, survival, and function: A systematic reviewThe effect of ketamine on mitochondrial bioenergetics, viability, and function: A systematic review.

Article

1 week ago • Journal of clinical psychopharmacology

TS-161, a drug blocking mGlu2/3 receptors, may help treat hard-to-treat depression: Early clinical trial resultsThe Antidepressant Effects of the mGlu2/3 Receptor Antagonist TS-161 in Treatment-Resistant Depression: A Phase IIa Proof-of-Concept Clinical Trial.

Article

1 week ago • The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry

Metabolic changes linked to intravenous ketamine in hard-to-treat major depressionMetabolomic correlates of intravenous racemic ketamine in treatment-resistant major depressive disorder: the Bio-K/NNDC multicenter trial.

Article

2 weeks ago • Journal of psychopharmacology (Oxford, England)

Brainwave changes caused by psilocybin connect immediate and lasting effectsPsilocybin-induced changes in electroencephalography link acute and long-term effects.

Article

2 weeks ago • Journal of psychopharmacology (Oxford, England)

Safety and body processing of intravenous deuterated N,N-dimethyltryptamine (CYB004) in healthy volunteersSafety, pharmacokinetics, and pharmacodynamics of intravenously administered deuterated N,N-dimethyltryptamine (CYB004) in healthy volunteers.

Article

2 weeks ago • Science (New York, N.Y.)

Psilocybin may prevent nerve damage from chemotherapy by protecting cell energy transportPsilocybin prevents chemotherapy-induced peripheral neuropathy through mitochondrial trafficking preservation.

Article

2 weeks ago • Science (New York, N.Y.)

Psychedelics as preventive brain protectorsPsychedelics as prophylactic neuroprotectants.

Comment

2 weeks ago • The Canadian journal of urology

Ketamine-related urinary tract damage: causes, problems, and treatmentsKetamine uropathy: an update on pathophysiology, complications, and treatment options.

Article

2 weeks ago • Journal of psychoactive drugs

Hallucinogen Use and Health Issues Among US Adults with Justice System Involvement, Including Other Drug Use and Demographic LinksJustice Involvement and Hallucinogen Use Among US Adults: Exploring Health Problems, Other Substance Use, and Demographic Correlates.

Article

2 weeks ago • Journal of psychoactive drugs

Age and Cannabis Use Are Linked to Differences in Psilocybin Experience and Perceived BenefitsAge and Cannabis Co-Use Are Associated with Differences in Experience and Perceived Benefits of Psilocybin: A Retrospective Study.

Article

2 weeks ago • Science academique

Can Psychedelics Help with Alcohol Use Disorder? Current Data Says NoCan Psychedelics help with Alcohol Use Disorder (AUD): For now, the data says no.

Article

2 weeks ago • Journal of psychoactive drugs

Factors Linked to Plans to Use Psilocybin for Mental Health Compared to Therapy, Psychiatric Drugs, and Natural or Synthetic TreatmentsFactors Associated with Intentions to Use Psilocybin for Mental Health in Relation to Psychotherapy, Psychiatric Medications, and Natural/Synthetic Options.

Article

2 weeks ago • Bipolar disorders

Improving Ketamine Infusion Treatment for Hard-to-Treat Bipolar Depression: Comments on Zhou et al. (2023)Optimizing Ketamine Infusion Therapy for Treatment-Resistant Bipolar Depression: Commentary on Zhou et al. (2023).

Article

2 weeks ago • Journal of psychopharmacology (Oxford, England)

Different psilocybin compounds affect fentanyl reward behavior in male and female miceDifferential effects of psilocybin derivatives on fentanyl-induced conditioned place preference in male and female mice.

Article

2 weeks ago • Journal of psychopharmacology (Oxford, England)

How N,N-dimethyltryptamine behaves and affects the body, and its safety, when given by IV to healthy smokers and non-smokersPharmacokinetics, pharmacodynamics and safety of N,N-dimethyltryptamine administered intravenously in healthy smoking and non-smoking volunteers.

Article

2 weeks ago • Journal of psychopharmacology (Oxford, England)

Immediate body and mind effects of different oral and under-the-tongue psilocybin and psilocin treatments in a controlled trialA randomized crossover trial comparing the acute physiological and psychological effects of botanical formulations of oral psilocybin, oral psilocin, and sublingual psilocin.

Article

3 weeks ago • Journal of neurophysiology

Brainwave Study of Antidepressant Effects of Ketamine Forms and Their Breakdown Products in MonkeysAn EEG-Based Evaluation of Antidepressant Effects of Ketamine Enantiomers and Metabolites in Monkeys.

Article

3 weeks ago • CNS drugs

New Drug Developments for Treating Unipolar Mood Disorders Using Different ApproachesNext-Generation Pharmacotherapies for Unipolar Mood Disorders: A Leading Article on Phase II/III Drug Development Across Diverse Mechanisms.

Article

3 weeks ago • Journal of psychopharmacology (Oxford, England)

Psilocybin changes rats' natural behaviors depending on the dose, beyond just causing head twitchesBeyond head-twitch response: Acute psilocybin affects spontaneous behaviors in rats in a dose-dependent manner.

Article

4 weeks ago • World journal of methodology

How Different Anesthetics (Propofol, Etomidate, Ketamine) Affect Seizure Length and Thinking Recovery During Electroconvulsive TherapyImpact of different anesthetic agents (propofol, etomidate, ketamine) on seizure duration and cognitive recovery in electroconvulsive therapy.

Article

1 month ago • Npj mental health research

Using ketamine or esketamine with psychotherapy to manage depression in adultsA scoping review: ketamine or esketamine when used to assist psychotherapy or in combination with psychotherapy for the management of depression in adults.

Article

1 month ago • Progress in neuro-psychopharmacology & biological psychiatry

Changes in memory system activity and adjustment during psychedelic therapyFrom network destabilisation to adaptive reconfiguration: A hippocampal longitudinal Axis model of psychedelic therapy.

Article

2 days ago • Npj mental health research

High ventilation breathwork as a non-pharmacological model for inducing psychedelic-like states: expert evaluations of therapeutic potential and risk.High ventilation breathwork as a non-pharmacological model for inducing psychedelic-like states: expert evaluations of therapeutic potential and risk.

Article

← prevpage 4 of 4next →